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80 The Journal of Thoracic and Cardiobjective: Intraoperative frozen section examination of sentinel lymph nodes was
onducted to determine the final indication for segmentectomy for clinical T1 N0
0 non–small cell lung cancer.
ethods: Between April 2005 and July 2006, 52 patients with clinical T1 N0 M0
on–small cell lung cancer were prospectively treated by segmentectomy with
entinel node identification. The day before surgery, technetium-99m tin colloid was
njected into the peritumoral region. After segmentectomy and lymph node dissec-
ion, sentinel nodes identified by measuring radioactive tracer uptake were exam-
ned for intraoperative frozen sections, which were serially cut 2 to 3 mm in
hickness. When sentinel node metastasis was observed, segmentectomy was con-
erted to lobectomy.
esults: Sentinel nodes were identified in 43 (83%) patients. The average number of
entinel nodes was 1.6  0.9 (range: 1–5) per patient. Of 3 patients with metastatic
entinel lymph nodes, 2 underwent lobectomy and 1 larger segmentectomy. None of
he other 40 patients had metastatic sentinel lymph nodes and therefore they were
reated with segmentectomy. Pathologic staging with permanent sections was N0 in
ll of the 40 patients. On the other hand, in 9 patients whose sentinel nodes could
ot be identified, intraoperative frozen sections were required for 5.4  2.3 lymph
odes, which was significantly more than 1.6  0.9 in the 43 patients with sentinel
ode identification (P  .001).
onclusion: Sentinel node identification is useful to determine the final indication of
egmentectomy for clinical T1 N0 M0 non–small cell lung cancer by targeting the
ymph nodes needed for intraoperative frozen section diagnosis.
n 1995, the Lung Cancer Study Group1 conducted a prospective randomized
controlled trial of limited resection versus lobectomy for clinical T1 N0 M0
non–small cell lung cancer (NSCLC) and concluded that the former was inferior
o the latter regarding local recurrence and survival. However, the limited resection
roup in the study included both segmentectomy and wedge resection, and the
urability for T1 N0 M0 NSCLC differed between the two procedures. On the other
and, there have been several reports describing that survivals were similar between
atients treated with segmentectomy and those with lobectomy.2-7
The most important issue regarding segmentectomy versus lobectomy is whether
ostoperative local recurrence is increased. Whereas Warren and Faber 8 reported
ocal recurrence in 15 (22.7%) of 66 patients after segmentectomy versus 5 (4.9%)
f 103 patients after lobectomy, other authors reported that local recurrence after
egmentectomy with complete dissection of hilar and mediastinal lymph nodes was
qual to that after lobectomy.3-6 However, for determining the final indication for
egmentectomy, intraoperative frozen sections must be examined for all of the hilar
vascular Surgery ● March 2007
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TSnd lobe-specific mediastinal lymph nodes to confirm the
ntraoperative N staging to be N0.3-6
A sentinel node (SN) is defined as the first lymph node
ithin the lymphatic basin reached by lymph draining from
he primary lesion. Recently, SNs have been identified by a
adioactive tracer with or without dye during surgery for
elanoma, breast cancer, gastrointestinal cancer, and lung
ancer to reduce lymph node dissection.9-14 We13,14 previ-
usly reported that SN identification with technetium-99m
in colloid could establish the first site of nodal metastasis in
SCLC.
In the present study, we used SN identification to target
he lymph nodes submitted for intraoperative frozen section
iagnosis, which might determine the indication of segmen-
ectomy. In addition, unlike Tsubota,3 Okada,4 Yoshikawa,5
nd their associates, who proposed that the indication for
egmentectomy was T1 N0 M0 NSCLC less than 2 cm in
ize, we proposed that it was T1 N0 M0 NSCLC without
ize limitation. Because SN identification served as the final
ndication of segmentectomy, we named the procedure
sentinel node navigation segmentectomy.”
atients and Methods
ligibility
he study protocol for SN navigation segmentectomy was ap-
roved by the Ethics Committee of Kumamoto University Hospital
n March 2005. Informed consent was obtained from all patients
fter discussing the risks and benefits of the proposed surgery with
heir surgeons.
atients
etween April 2005 and July 2006, 103 patients with NSCLC
nderwent surgical treatment. Of these, 73 patients had stage c-T1
0 M0 cancer according to the findings of both computed tomog-
aphy (CT) and fluorodeoxyglucose–positron emission tomogra-
hy (FDG-PET). SN navigation segmentectomy was prospectively
erformed when (1) c-T1 N0 M0 NSCLC was identified in the
eripheral lung; (2) the tumor on CT was more than 2 cm away
rom the pulmonary vein running at the boundary of the affected
egment; (3) intraoperative frozen sections of SN showed no
etastasis; (4) the surgical margin was intraoperatively found to
e more than 2 cm from the tumor; and (5) tumors located
entrally within the inner one third of the lung or in the right
Abbreviations and Acronyms
CT  computed tomography
FDG-PET fluorodeoxyglucose–positron emission
tomography
NSCLC  non–small cell lung cancer
SN  sentinel node
SPECT  single photon emission computed
tomographyiddle lobe were excluded. The stage of disease was based on the a
The Journal of ThoracicNM classification of the International Union Against Cancer.15
he lymph node nomenclature used was according to the lymph
ode map of Naruke and associates,16 which was approved by the
apan Lung Cancer Society (Table 1).
dministration of Radioactive Colloid
he day before surgery, a 23-gauge needle was introduced into the
eritumoral region under single photon emission computed tomogra-
hy/computed tomography (SPECT/CT) system guidance, which in-
orporates a gantry-free SPECT with dual-head detectors (Sky-
ight; ADAC Laboratories, Milpitas, Calif) and an 8 multidetector
T scanner (Light-Speed Ultra; General Electrics, Milwaukee,
is). Technetium tin colloid (68 mCi) suspended in a 1- to
.5-mL volume was injected in a single shot. SPECT/CT was
erformed 5 minutes after the injection and the next morning just
efore the operation.
N Identification
he radioactivity of the resected lymph nodes was counted with a
andheld gamma probe (Navigator; Auto Suture Japan, Tokyo,
apan). The radioactivity was measured for a 10-second period. SN
as defined as any node for which the count was more than 5 times
he radioactivity of the resected tissue with the lowest count.
N Navigation Segmentectomy
nder thoracotomy, SN navigation segmentectomy was performed
s follows: (1) Pulmonary arteries and bronchi of the affected
egments were cut at the hilum; (2) pulmonary veins along the
oundary of segments were isolated from the center to periphery;
3) the affected segments along the pulmonary veins were resected
ith staplers; (4) the hilar and systematic mediastinal lymph nodes
ere dissected; (5) the radioactivity of dissected lymph nodes was
ounted for SN identification; (6) SNs were examined by intraop-
rative frozen sections, which were serially cut 2 to 3 mm in
hickness; (7) if the intraoperative frozen sections of the SN
howed no metastasis, the operation was completed with segmen-
ectomy; (8) if the sections of the SN showed metastasis, lobec-
omy was performed; and (9) if the SN could not be identified
ecause radioactivity of the lymph nodes was low, all of the hilar
ABLE 1. Lymph node nomenclature
2 node N1 node
uperior mediastinal Hilar
No. 1. Highest mediastinal No. 10. Hilar
No. 2. Paratracheal No. 11. Interlobar
No. 3. Pretracheal No. 12. Lobar
No. 4. Tracheobronchial
ortic Intrapulmonary
No. 5. Botallo No. 13. Segmental
No. 6. Para-aortic No. 14. Subsegmental
nferior mediastinal
No. 7. Subcarinal
No. 8. Paraesophageal
No. 9. Pulmonary ligamentnd lobe-specific mediastinal lymph nodes were submitted for
and Cardiovascular Surgery ● Volume 133, Number 3 781
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G
TSntraoperative frozen section. Lobe-specific lymph nodes were
efined as follows: No. 3 and No. 4 for the right upper lobe, No.
for the left upper lobe, and No. 7 for the lower lobe of both
ides.17
rimary End Points of the Study
rimary end points of the study are as follows: (1) Can SN
dentification diagnose pathologic N stage during segmentectomy?
2) Are the survival and local recurrence after SN navigation
egmentectomy similar to those after lobectomy?
tatistical Analysis
ll data were analyzed for significance by the 2-tailed Student
tests. All values in the text and tables are given as mean  SD.
esults
perative procedures for the 73 patients with c-T1 N0 M0
ere lobectomy in 12 patients, segmentectomy in 52, and
edge resection in 9. The reasons for conducting lobectomy
n the 12 patients were as follows: (1) tumors in the right
iddle lobe in 5 patients; (2) tumors located centrally in 5
atients; (3) multiple lesions in the same lobe in 1 patient;
nd (4) thoracoscopic lobectomy as requested by the patient.
s a result, 52 patients were consecutively enrolled for SN
avigation segmentectomy. Table 2 shows the sites of seg-
entectomy for the 52 patients. The average number of
issected lymph node stations and lymph nodes per patient
as 6  1.8 stations and 12.5  5.9 lymph nodes, respec-
ively. Among the 52 patients, SNs could be identified in 43
ABLE 2. Sites of segmentectomy
egment
No. of
patients Segment
No. of
patients
ight Left
Upper lobe Upper lobe
S1 3 S1 2 4
S2 2 S3 2
S1  S2 2 S1 2  3 9
S3 2 S4 5 7
S3  S2b 1
S2  S3a 1
Lower lobe Lower lobe
S6 4 S6 3
S7  8 1 S8 1
S8 1 S8 9 2
S9  S10 2 S9 10 1
S710 1 S10 1
S6  S9  S10 1 S810 1
otal 21 31
ight upper lobe: S1, apical; S2, anterior; S3, posterior. Right lower lobe:
6, apical; S7, medial; S8, anterior; S9, lateral; S10, posterior. Left upper
obe: S12, apical posterior; S3, apical anterior; S4, superior lingular; S5,
nferior lingular. Left lower lobe: S6, apical; S8, anterior; S9, lateral; S10,
osterior.83%). The time needed for SN identification was within 5 d
82 The Journal of Thoracic and Cardiovascular Surgery ● Marcinutes in each patient. The characteristics of the 43 pa-
ients with SN identification and of the 9 patients without
re shown in Table 3. Average tumor size on CT was 1.9 
.7 cm (range: 0.8–3.0 cm) and 2.1  0.7 cm (range:
.4–3.0 cm) in the patients with and without SN identifi-
ation, respectively. Seventeen (40%) of the 43 patients
ith SN identification and 4 (44%) of 9 patients without had
umors larger than 2 cm. Pathologic tumor stages in the 43
atients with SN identification were T1 N0 M0 in 39, T2 N0
0 in 1, T1 N1 M0 in 1, T2 N1 M0 in 1, and T1 N2 M0 in
, whereas the stage in all 9 patients without SN identifi-
ation was p-T1 N0 M0. The tumors in 2 patients were
athologically classified as T2; one tumor was spread over
he pleura and the other was more than 3 cm in size in the
ermanent section. The average number of lymph nodes
ubmitted for intraoperative frozen section examination was
ignificantly less in the 43 patients with SN identification
1.6  0.9 [range: 1–5] per patient) than in the 9 patients
ithout SN identification (5.4  2.3 [range: 3–10] per
atient) (P  .001).
Table 4 shows the SN identified in the hilar lymph node
tations. The number of stations having SN increased in
umeric order from No. 10 to 13 stations. In the mediastinal
ymph node stations, the SN was identified in 15 of the 43
atients (35%). Eleven of the 15 patients had SNs in both
he hilar and mediastinal lymph node stations, whereas the
emaining 4 patients had SNs only in the mediastinum. The
ABLE 3. Characteristics of patients with and without
entinel node identification
Sentinel lymph node
Identifiable Nonidentifiable
ean age (y) 69 7 71  7
ex
Male 26 8
Female 17 1
ean tumor size (cm) 1.9 0.7 2.1  0.7
istologic type
Adenocarcinoma 37 6
Squamous cell carcinoma 4 2
Adenosquamous carcinoma 2 1
o. of lymph nodes submitted
for intraoperative frozen
diagnosis
1.6  0.9 5.4  2.3*
athologic TNM
T1 N0 M0 39 9
T2 N0 M0 1 0
T1 N1 M0 1 0
T2 N1 M0 1 0
T1 N2 M0 1 0
otal 43 9
P  .001.istribution of mediastinal SNs is shown in Table 5, which
h 2007
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G
TSas lobe-specific; that is, 3 of the 10 patients with primary
umor in the right upper lobe had SN in No. 3 or 4 stations;
of the 9 patients with primary tumor in the right lower
obe had SN in No. 7, 3, or 4 stations; 8 of the 18 patients
ith primary tumor in the left upper lobe had SN in No. 5
tation; and 2 of the 6 patients with primary tumor in the left
ower lobe had SN in No. 7 station.
In 3 (7%) of the 43 patients with SN identification,
etastasis was found in the SN by intraoperative frozen
ection (Table 6). For 2 of the 3 patients (patients 1 and 2),
perative procedures were converted to lobectomy. The
perative procedure for the remaining patient (patient 3)
as converted from posterior apical segmentectomy to
arger segmentectomy (upper division segmentectomy, but
ot to upper lobectomy), because of his age (80 years old).
athologic N stages were N1 in 2 patients and N2 in 1
atient. Although both patients 1 and 2 had metastasis only
n the SN, patient 3 had metastasis in both SN (No. 5) and
on-SN (Nos. 12 and 13). Tumors in all of the other 40
atients were classified as p-N0 by permanent sections.
There were no complications associated with radioiso-
ope injection necessitating tube drainage, such as bleeding
r severe pneumothorax. One patient had empyema 3 days
fter segmentectomy, which was cured by drainage and
ntibiotics on the 23rd postoperative day. There were no the
ther major complications associated with segmentectomy,
ncluding prolonged air leakage of more than 5 days. The
ostoperative follow-up was performed by chest and ab-
ominal CT and brain magnetic resonance imaging every 3
onths after the operation. No patients were lost to follow-
p. The mean follow-up period after surgery in the 52
atients was 8 months (range: 1–15 months). Postoperative
ecurrence occurred in 1 patient, who underwent an apical
egmentectomy of the right lower lobe for adenosquamous
arcinoma 2.9 cm in size. The recurrence was at 5 months
fter segmentectomy, at the extraregional lymph node for
umor in the right lower lobe, that is, at the interlobar lymph
ode (No. 11) between the right upper lobe and middle lobe,
nd treated by completion pneumonectomy. During the
egmentectomy of this patient, No. 13 and No. 4 were
dentified as SNs, which showed no metastasis in intraop-
ABLE 4. Sentinel lymph node mapping in the hilar lymph
ode stations
tation
Sentinel nodes
No. of patients Percent
10 7/3 16.3
11 7/43 16.3
12 12/43 27.9
13 22/43 51.2rative frozen sections. The patient is now alive 11 months t
The Journal of Thoracicfter the completion pneumonectomy without recurrence.
he other 51 patients are also now alive without recurrence.
iscussion
he present study shows that the SN navigation segmentec-
omy using radioisotope tracers could increase the accuracy
f intraoperative N staging and could serve as the final
ndication for segmentectomy. In the 3 patients with N1 or
2 disease, intraoperative frozen sections of SNs showed
etastasis, which suggested the need for lobectomy. In 9
egmentectomy-treated patients whose SNs could not be
dentified, all hilar and lobe-specific lymph nodes were
equired for diagnosis, a significantly larger number than in
he 43 patients whose SNs could be identified. SN identifi-
ation therefore could determine a final indication for seg-
entectomy by targeting the lymph nodes needed for intra-
perative frozen section diagnosis. In addition, serial
ections of SNs during surgery might find micrometastasis
ore easily than single section in each of a larger number of
ymph nodes.
Although the postoperative follow-up period is still
hort, 1 patient had local recurrence 5 months after segmen-
ectomy. The recurrence site of this patient, however, was
he extraregional lymph node. In addition, the histologic
ype of this patient was adenosquamous carcinoma, which is
nown to have poorer prognosis than other types of
SCLC.18,19 We therefore consider that the patients with
linical T1 N0 M0 NSCLC of high malignant grade, such as
denosquamous carcinoma, large cell neuroendocrine car-
inoma, adenocarcinoma with high FDG uptake on PET,
nd NSCLC with high carcinoembryonic antigen serum
evel, would be preferably treated by lobectomy rather than
egmentectomy, even if the intraoperative lymph node stag-
ng is N0.
Skip metastasis to the mediastinal lymph nodes has been
eported to occur in 20% to 40% of patients with
SCLC,17,20 which could be because some lymphatic flow
rom the lung goes directly to the mediastinum through the
leura and not to the hilar lymph node stations.21 The
resent study showed that SNs were identified in the medi-
stinum in 15 (35%) of 43 patients and the lymphatic route
ABLE 5. Sentinel nodes at the mediastinum in each lobe
umor location Station of mediastinal SN No. of patients Percent
UL 3 or 4 3/10 30.0
LL 3 or 4 2/9 22.2
7 and 3 1/9 11.2
UL 5 8/18 44.4
LL 7 2/6 33.3
N, Sentinel node; RUL, right upper lobe; RLL, right lower lobe; LUL, left
pper lobe; LLL, left lower lobe.o each mediastinal lymph node station was lobe-specific.
and Cardiovascular Surgery ● Volume 133, Number 3 783
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7
G
TSherefore, to determine the intraoperative indication for
egmentectomy without using SN identification, not only
ilar lymph nodes but also lobe-specific mediastinal lymph
odes should be submitted for intraoperative frozen section
iagnosis. The SN identification can target the lymph nodes
mong those.
The identification rate of SNs was 83% in the present
tudy, as it was in the data of previous reports by several
uthors, that is, 63% to 82%.12-14 We14 previously reported
he results of SN identification in 104 patients with clinical
tage I NSCLC. Of the 104 patients, 15 patients had N1 or
2 disease. Although SN could be found to have metastases
uring the operation in 13 (87%) of those 15 patients, it
roduced false negative results in the remaining 2 patients.
ne of the 2 patients had T2 tumor and metastasis in the No.
2 nodal station, and the other had T1 tumor and metastasis
n the No. 14 nodal station, which could not be identified as
N by our procedure because of its intrapulmonary location.
e therefore believe that SN could be identified by our
rocedure in most of the patients with T1 N0 M0 NSCLC.
Although it has been reported that 20% to 25% of pa-
ients with clinical stage I disease have mediastinal lymph
ode metastasis,22,23 the present study showed only 3 (6%)
f 52 patients with N1 or N2 disease. Our procedure for
ymph node dissection was systematic and then yielded 6 
.8 nodal stations and 12.5 6 lymph nodes to be dissected
er patient. The low number of patients with N1 or N2
isease in the present study is probably due to the institu-
ional setting; that is, most lung cancers in our patients were
ound by routine CT examination, resulting in a higher rate
f early-stage NSCLC than usual.
The Lung Cancer Study Group study in 1995 (the only
rospective randomized trial of lobectomy versus limited
esection for T1 N0 NSCLC) reported that limited resection
as inferior to lobectomy regarding death rate and local
ecurrence.1 However, the study included a significant num-
er (33%) of wedge resections in the limited resection group
nd did not analyze the results of segmentectomy. In addi-
ion, compared with clinical staging in 1995 when the Lung
ancer Study Group study was reported, it is now more
ccurate because of improved CT and FDG-PET technol-
gy. Therefore, a prospective randomized trial of lobectomy
ABLE 6. Patients who were converted to major lung rese
atient No. Age/sex
Histologic
type Planned segment
1 70/M Ad Apical segment of RL
2 72/M Ad Apical segment of RL
3 80/M Ad Posterior apical segm
N, Sentinel node; Ad, adenocarcinoma; RLL, right lower lobe; LUL, left uersus segmentectomy should be performed for c-T1 N0
1
84 The Journal of Thoracic and Cardiovascular Surgery ● Marc0 NSCLC. The SN navigation segmentectomy, which can
arget lymph nodes for intraoperative frozen section diag-
osis, is a reasonable procedure for determining the final
ndication of segmentectomy.
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